Postoperative Chemoradiotherapy and Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck: Radiation Therapy Oncology Group RTOG-0234

PURPOSE: To report results of a randomized phase II trial (Radiation Therapy Oncology Group RTOG-0234) examining concurrent chemoradiotherapy and cetuximab in the postoperative treatment of patients with squamous cell carcinoma of the head and neck (SCCHN) with high-risk pathologic features. PATIENT...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Harari, Paul M., Harris, Jonathan, Kies, Merrill S., Myers, Jeffrey N., Jordan, Richard C., Gillison, Maura L., Foote, Robert L., Machtay, Mitchell, Rotman, Marvin, Khuntia, Deepak, Straube, William, Zhang, Qiang, Ang, Kian
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2014
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4121506/
https://ncbi.nlm.nih.gov/pubmed/25002723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.53.9163
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados